Taboco, Naome .
HRN: 23-03-75 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/19/2023
CEFUROXIME 750MG (VIAL)
11/19/2023
11/25/2023
IV
1.5gm
Q8
SPTAHBSO
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft TissueIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes